JPMorgan Downgrades Boston Scientific to Neutral, Cuts Target to $46
FROM THE WIRE · GURUFOCUS.COM
On October 28, 2026, JPMorgan downgraded Boston Scientific Corp (NYSE: BSX) from an Overweight rating to Neutral and cut its price target from $56 to $46. This
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA major bank's downgrade of a large-cap stock can weigh on the shares in the short term.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01On October 28, 2026, JPMorgan downgraded Boston Scientific from Overweight to Neutral.
- 02The price target was cut from $56 to $46.
- 03The downgrade cites pipeline delays and lower guidance.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets